Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nivolumab in Relapsed or Refractory Follicular Lymphoma
NCT02038946Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Mar 2014
- Primary completion
- May 2017
- Modality
- Monoclonal Antibodies
- Countries
- 12
01
Overview
A Phase 2 trial of nivolumab in follicular lymphoma (FL), sponsored by Bristol Myers Squibb. Started Mar 2014; status: completed.
02
Drugs
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT02038946.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02038946.